Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia
Mayo Clinic
Mayo Clinic
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center